Intra-Cellular Therapies Overview

Intra-Cellular Therapies Total Revenue

Revenue analysis for ITCI.

Quarterly Revenue

$199.22M

↑ 51.49% YoY

As of Dec 2024

Annual Revenue (TTM)

$680.64M

↑ 47.27% YoY

Trailing 12 months ending Dec 2024

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin